Psoriasis clinical trials in California
14 studies for Psoriasis are looking for participants at sites in California.
Cities in California
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Fremont
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07362017The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07487831A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- and 1 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Local Institution - 0025, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Dermatology Research Associates, Los Angeles
- and 3 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 3, 2026 · NCT06979453A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, Fountain Valley
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07013201A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50176, Fremont
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07219420The Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Liao Lab at UCSF, San Francisco
Recruiting
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07390487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Chula Vista
- Study Center, Fountain Valley
- Study Center, Fremont
- and 3 more
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 9, 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- University of California, Davis - Dermatology Department, Sacramento
Recruiting
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT06574178A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- Bausch Site 2, Thousand Oaks
RecruitingPhase 4
Ages 6 to 17 · All sexes · Updated Aug 27, 2025 · NCT03987763Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Kinetic Clinical Research, Anaheim
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Aug 7, 2025 · NCT06846710A Study to Assess Deucravacitinib Safety in Pregnancy
- University of California San Diego, La Jolla
RecruitingObservational studyHealthy volunteers welcome
All ages · Women · Updated Jun 12, 2025 · NCT07017699Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
RecruitingObservational study
All ages · Women · Updated Jan 28, 2025 · NCT02103361From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.